Literature DB >> 17530718

Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.

Francesca Ferrera1, Bevra H Hahn, Marta Rizzi, Marissa Anderson, John Fitzgerald, Enrico Millo, Francesco Indiveri, Fu-Dong Shi, Gilberto Filaci, Antonio La Cava.   

Abstract

OBJECTIVE: Ig molecules contain epitopes that can induce T cell-mediated immune responses. B cells can process and present such epitopes and activate T cells. The purpose of the present study was to test our hypothesis that T cells that recognize an Ig consensus sequence presented by B cells will modulate lupus-like disease in mice.
METHODS: (NZB x NZW)F(1) (NZB/NZW) lupus mice received somatic B cell gene transfer of a DNA plasmid encoding a consensus sequence of T cell determinants of murine anti-DNA IgG or control plasmids. Treated animals were monitored for the production of antibody, the development of renal disease, and the phenotype, number, and function of T cells.
RESULTS: Treatment of mice with Ig consensus plasmid induced transforming growth factor beta-producing CD8+,CD28- T cells that suppressed the antigen-specific stimulation of CD4+ T cells in a cell-contact-independent manner, reduced antibody production, retarded the development of nephritis, and improved survival. Significantly, adoptive transfer of CD8+,CD28- T cells from protected mice into hypergammaglobulinemic NZB/NZW mice effectively protected the transferred mice from the development of renal disease.
CONCLUSION: Gene expression of anti-DNA Ig consensus sequence induces immunoregulatory T cells that delay the development of lupus nephritis by suppressing hypergammaglobulinemia and renal disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17530718     DOI: 10.1002/art.22700

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

Review 1.  Current and novel therapeutics in the treatment of systemic lupus erythematosus.

Authors:  Cagri Yildirim-Toruner; Betty Diamond
Journal:  J Allergy Clin Immunol       Date:  2011-02       Impact factor: 10.793

2.  Suppression of Murine Lupus by CD4+ and CD8+ Treg Cells Induced by T Cell-Targeted Nanoparticles Loaded With Interleukin-2 and Transforming Growth Factor β.

Authors:  David A Horwitz; Sean Bickerton; Michael Koss; Tarek M Fahmy; Antonio La Cava
Journal:  Arthritis Rheumatol       Date:  2019-03-05       Impact factor: 10.995

3.  Early and repeated IgG1Fc-pCons chimera vaccinations (GX101) improve the outcome in SLE-prone mice.

Authors:  Francesca Ferrera; Daniela Fenoglio; Maurizio Cutolo; Giuseppe Balbi; Alessia Parodi; Florinda Battaglia; Francesca Kalli; Domenico Barone; Francesco Indiveri; Domenico Criscuolo; Gilberto Filaci
Journal:  Clin Exp Med       Date:  2014-07-25       Impact factor: 3.984

Review 4.  Modulation of autoimmunity with artificial peptides.

Authors:  Antonio La Cava
Journal:  Autoimmun Rev       Date:  2010-08-31       Impact factor: 9.754

5.  MiR-663a/MiR-423-5p are involved in the pathogenesis of lupus nephritis via modulating the activation of NF-κB by targeting TNIP2.

Authors:  Weisong Wang; Junjie Gao; Fangli Wang
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 6.  Induction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone mice.

Authors:  Brian J Skaggs; Ram Pyare Singh; Bevra H Hahn
Journal:  Hum Immunol       Date:  2008-09-24       Impact factor: 2.850

7.  Generation of gene-engineered chimeric DNA molecules for specific therapy of autoimmune diseases.

Authors:  Vera Gesheva; Zsuzsanna Szekeres; Nikolina Mihaylova; Iliyana Dimitrova; Maria Nikolova; Anna Erdei; Jozsef Prechl; Andrey Tchorbanov
Journal:  Hum Gene Ther Methods       Date:  2012-11-23       Impact factor: 2.396

Review 8.  Cytokines in systemic lupus erythematosus.

Authors:  Elaine V Lourenço; Antonio La Cava
Journal:  Curr Mol Med       Date:  2009-04       Impact factor: 2.222

9.  Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus.

Authors:  Noriko Iikuni; Elaine V Lourenço; Bevra H Hahn; Antonio La Cava
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

10.  A20 overexpression alleviates pristine-induced lupus nephritis by inhibiting the NF-κB and NLRP3 inflammasome activation in macrophages of mice.

Authors:  Min Li; Xiaowei Shi; Tian Qian; Jian Li; Zhiqiang Tian; Bing Ni; Fei Hao
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.